Product Information
CLIND PH-BENZOYL PERO 1.2-2.5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7422 per GM under NDC 45802059701. Its NADAC has been published 350 times since Dec 11, 2019.
FDA first approved this application on Sep 9, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 10 mg/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802059701
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA205397FDA Approved
9/9/2019
TE Code
AB
On Market Since
9/12/2019
Pharmacological Classes
Price Statistics
The NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has been published 350 times since Dec 11, 2019, and over the history we have for it it has declined 90.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7422 per GM |
|---|---|
| All-time high | $7.4004 (Mar 11, 2020) |
| All-time low | $0.6671 (Jul 22, 2026) |
| 52-week high | $1.1594 |
| 52-week low | $0.6671 |
| Median price | $1.2908 |
| Average price | $1.5856 |
| Largest weekly change | +71.0% (Feb 22, 2023) |
| Weeks tracked | 350 |
| Tracking since | Dec 11, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clindamycin Phosphate, Benzoyl Peroxide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLIND PH-BENZOYL PERO 1.2-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PERO 1.2-2.5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7422 per GM (NDC 45802059701), effective Aug 19, 2026.
How has the price of CLIND PH-BENZOYL PERO 1.2-2.5% changed over time?
Over the history we have for it, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has declined 90.0%. It has been tracked across 350 weekly CMS publications since Dec 11, 2019.
What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PERO 1.2-2.5%?
Since Dec 11, 2019, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has ranged from a low of $0.6671 (Jul 22, 2026) to a high of $7.4004 (Mar 11, 2020), with a median of $1.2908 per GM.
Are there cheaper alternatives to CLIND PH-BENZOYL PERO 1.2-2.5%?
No other NADAC-published product currently shares the active ingredient and strength of CLIND PH-BENZOYL PERO 1.2-2.5% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLIND PH-BENZOYL PERO 1.2-2.5%?
CLIND PH-BENZOYL PERO 1.2-2.5% (NDC 45802059701) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.